PTGX
Protagonist Therapeutics (PTGX)
$96
About Protagonist Therapeutics (PTGX)
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Details
Daily high
$119.85
Daily low
$114.56
Price at open
$114.66
52 Week High
$119.85
52 Week Low
$49.38
Market cap
7.4B
Dividend yield
0.00%
Volume
661,241
Avg. volume
701,149
P/E ratio
-63.77
Protagonist Therapeutics News
Details
Daily high
$119.85
Daily low
$114.56
Price at open
$114.66
52 Week High
$119.85
52 Week Low
$49.38
Market cap
7.4B
Dividend yield
0.00%
Volume
661,241
Avg. volume
701,149
P/E ratio
-63.77